Table 5 Region-specific positive biopsies, stratified by the number of biopsy sessions
Region | Number of biopsy sessions | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
1 n % | 2 n (%) | 3 n (%) | 4+ n (%) | All n (%) | ||||||
Base | ||||||||||
1 | 15 | 19.0% | 23 | 15.8% | 11 | 13.1% | 9 | 14.1% | 58 | 15.5% |
2 | 16 | 20.3% | 19 | 13.0% | 7 | 8.3% | 5 | 7.8% | 47 | 12.6% |
3 | 13 | 16.5% | 8 | 5.5% | 4 | 4.8% | 3 | 4.7% | 28 | 7.5% |
4 | 11 | 13.9% | 4 | 2.7% | 2 | 2.4% | 1 | 1.6% | 18 | 4.8% |
5 | 17 | 21.5% | 19 | 13.0% | 7 | 8.3% | 4 | 6.3% | 47 | 12.6% |
6 | 20 | 25.3% | 17 | 11.6% | 7 | 8.3% | 5 | 7.8% | 49 | 13.1% |
7 | 10 | 12.7% | 18 | 12.3% | 9 | 10.7% | 8 | 12.5% | 45 | 12.1% |
8 | 17 | 21.5% | 21 | 14.4% | 10 | 11.9% | 7 | 10.9% | 55 | 14.7% |
Midgland | ||||||||||
9 | 20 | 25.3% | 22 | 15.1% | 10 | 11.9% | 8 | 12.5% | 60 | 16.1% |
10 | 17 | 21.5% | 20 | 13.7% | 4 | 4.8% | 6 | 9.4% | 47 | 12.6% |
11 | 22 | 27.8% | 19 | 13.0% | 6 | 7.1% | 4 | 6.3% | 51 | 13.7% |
12 | 17 | 21.5% | 14 | 9.6% | 8 | 9.5% | 4 | 6.3% | 43 | 11.5% |
13 | 17 | 21.5% | 13 | 8.9% | 5 | 6.0% | 2 | 3.1% | 37 | 9.9% |
14 | 18 | 22.8% | 18 | 12.3% | 4 | 4.8% | 3 | 4.7% | 43 | 11.5% |
15 | 13 | 16.5% | 18 | 12.3% | 5 | 6.0% | 5 | 7.8% | 41 | 11.0% |
16 | 14 | 17.7% | 23 | 15.8% | 9 | 10.7% | 5 | 7.8% | 51 | 13.7% |
17 | 14 | 17.7% | 18 | 12.3% | 12 | 14.3% | 8 | 12.5% | 52 | 13.9% |
18 | 15 | 17.7% | 26 | 17.8% | 8 | 9.5% | 8 | 12.5% | 56 | 15.0% |
Apex | ||||||||||
19 | 28 | 35.4% | 34 | 23.3% | 16 | 19.0% | 11 | 17.2% | 89 | 23.9% |
20 | 23 | 29.1% | 21 | 14.4% | 7 | 8.3% | 4 | 6.3% | 55 | 14.7% |
21 | 20 | 25.3% | 16 | 11.0% | 7 | 8.3% | 5 | 7.8% | 48 | 12.9% |
22 | 14 | 17.7% | 14 | 9.6% | 6 | 7.1% | 5 | 7.8% | 39 | 10.5% |
23 | 14 | 17.7% | 26 | 17.8% | 11 | 13.1% | 3 | 4.7% | 54 | 14.5% |
24 | 22 | 27.8% | 37 | 25.3% | 20 | 23.8% | 8 | 12.5% | 87 | 23.3% |